💊#Elacestrant is a novel oral #SERD that selectively binds to the estrogen receptor in #BC cells, inhibiting tumor growth. But, how do the data on this novel drug look so far❓ Here’s a great review: https://t.co/xPgq2t9WEO #MedEd #BreastCancer #oncology
1,294 followers
3,355 followers
Recently published in OncoTargets and Therapy: Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date 🔗https://t.co/aVgLKicsnB #Research #BreastCancer #Elacestrant #RAD1901
9,924 followers
RT @MCristofanill: Elacestrant in management of ER-Positive, HER2-Negative BC | OTT @DovePress https://t.co/MvnsVwMzXF
2,301 followers
Elacestrant in management of ER-Positive, HER2-Negative BC | OTT @DovePress https://t.co/MvnsVwMzXF